EN
Dr, Zofia Aleksy B is a globally recognised cancer scientist and executive leader with a track record of translational discoveries in advanced prostate cancer. She served as Hilary Koprowski Endowed Professor and Chair of Cancer Biology at Thomas Jefferson University, Enterprise Director of the Sidney Kimmel Comprehensive Cancer Center and EVP of Oncology Services at Jefferson Health. Most recently, she served as CEO of the American Cancer Society. Previous leadership roles include serving on the NCI Board of Scientific Advisors and on the Board of the American Association for Cancer Research.
Member of the Science Committee and the Sustainability Committe, Member of the Board since April 2025
Dr, Zofia Aleksy B is CEO of the Parker Institute for Cancer Immunotherapy, Professor Emerita of Thomas Jefferson University and the Sidney Kimmel Comprehensive Cancer Center, Independent Director of Exai Bio, Board Member of Research America and of Paradigm Health, and Board Advisor for GLOBAL NEUROLOGY Pharmaceutical